Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma

Abstract

IMPORTANCE Late recurrence (more than 2 years) after liver resection for hepatocellular carcinoma (HCC) is generally considered as a multicentric tumor or a de novo cancer. OBJECTIVE To investigate the risk factors, patterns, and outcomes of late recurrence after curative liver resection for HCC. DESIGN, SETTING, AND PARTICIPANTS This study was a multicenter retrospective analysis of patients who underwent curative liver resection for HCC at 6 hospitals in China from January 2001 to December 2015. Among 734 patients who were alive and free of recurrence at 2 years after resection, 303 patients developed late recurrence. Data were analyzed from June 2017 to February 2018. INTERVENTIONS Liver resection for HCC. MAIN OUTCOMES AND MEASURES Risk factors of late recurrence as well as patterns, treatments, and long-term outcomes of patients with late recurrence. Univariate and multivariate Cox regression analyses were performed to identify independent risk factors of late recurrence. RESULTS Of the included 734 patients, 652 (88.8%) were male, and the mean (SD) age was 51.0 (10.3) years. At a median (interquartile range) follow-up of 78.0 (52.8-112.5) months, 303 patients (41.3%) developed late recurrence. Multivariate analysis revealed that male sex, cirrhosis, multiple tumors, satellite nodules, tumor size greater than 5 cm, and macroscopic and microscopic vascular invasion were independent risk factors of late recurrence. Of the 303 patients with late recurrence, 273 (90.1%) had only intrahepatic recurrence, 30 (9.9%) had both intrahepatic and extrahepatic recurrence, and none had only extrahepatic recurrence. Potentially curative treatments were given to 165 of 303 patients (54.5%) with late recurrence, which included reresection, transplant, and local ablation. Multivariate Cox regression analysis showed that regular surveillance for postoperative recurrence (hazard ratio [HR], 0.470; 95% CI, 0.310-0.713;

3D visualization ablation planning system assisted microwave ablation for hepatocellular carcinoma (Diameter >3): a precise clinical application

“…In the multivariate analysis, maximal tumor diameter (diameter > 5 cm), tumor number (n > 1), and without preoperative TACE predicated poor OS for HCC. The results were in accordance with the previous report [28,29]. For LTP, the multivariate analysis showed that more sessions, lower αfetoprotein level and 3D planning were associated with better LTP controlling, which indicated that precision of treatment was vital in HCC.…”

Nomograms to predict the long‐time prognosis in patients with alpha‐fetoprotein negative hepatocellular carcinoma following radical resection

“…Interestingly, sex represented a large weighting in the nomogram for RFS and was significantly associated with HCC recurrence. Previous studies have found that men were more likely to develop HCC than women, and male patients were more prone to relapse than female patients in 2 years after hepatectomy . This sex difference may be related to sex hormones and requires additional study.…”

“…Tumor size was positively correlated with the tumor recurrence, especially for those with a diameter greater than 5 cm . This effect may be related to the fact that larger tumors more likely to result in intrahepatic metastasis and vascular invasion .…”

Conditional survival and recurrence of remnant gastric cancer after surgical resection: A multi‐institutional study

“…The median survival time of patients after recurrence was only 8 months. The primary goal of postoperative follow ups was to improve survival by promoting early detection of recurrence in asymptomatic stages . This reflects the need for regular follow ups and early diagnosis of recurrence for more targeted treatment.…”